BioMed Research International / 2020 / Article / Tab 3 / Research Article
Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry Table 3 Clinical symptoms in patients with PAH and CTEPH.
Clinical symptoms Patient groups IPAH ( ) PAH-CTD ( ) PAH-CHD ( ) PoPH ( ) PAH group ( ) CTEPH group ( ) Onset ( , %) Time of diagnosis verification ( , %) Onset ( , %) Time of diagnosis verification ( , %) Onset ( , %) Time of diagnosis verification ( , %) Onset ( , %) Time of diagnosis verification ( , %) Onset ( , %) Time of diagnosis verification ( , %) Onset ( , %) Time of diagnosis verification ( , %) Dyspnea 171 (85.9%)2 197 (98.9%) 89 (94.7%)4 92 (97.8%) 173 (97.2%)4 178 (100%) 7 (77.8%) 9 (100%) 425 (87.3%) 483 (99.2%) 189 (91.7%) 202 (98.1%) Fatigue 66 (33.1%) 129 (64.8%)4 32 (34.0%) 72 (76.6%) 40 (22.5%)4 122(68.5%)4 5 (55.6%) 8 (88.9%) 242 (49.7%) 362 (74.3%)# 63 (30.6%) 163 (79.1%)# Chest pain 34 (17.1%) 82 (41.2%) 12 (12.8%)2 48 (51.2%) 39 (21.9%)4 90 (50.6%)4 1 (11.1%) 3 (33.3%) 72 (14.8%) 212 (43.5%)# 70 (33.9%) 91 (44.2%) Dizziness 45 (22.6%)4 90 (45.2%)4 22 (23.4%)4 38 (40.4%)4 41 (23.0%)4 84 (47.2%)4 1 (11.1%) 2 (22.2%) 75 (15.4%) 188 (38.6%) 21 (10.2%) 110 (53.4%)# Syncope 51 (25.6%)4 55 (27.6%)2.4 1 (1.1%)1 11 (11.7%)1.4 14 (7.9%)4 22 (12.4%)4 0 (0%) 0 (0%) 75 (15.4%) 125 (25.7%) 40 (19.4%) 25 (12.1%) Palpitations 76 (38.2%) 128 (64.3%)2 32 (34.0%) 78 (82.9%)1 41 (23.0%) 80 (44.9%)4 2 (22.2%) 7 (77.8%) 120 (24.6%) 312 (64.1%)# 48 (23.3%) 106 (51.5%)# Cough 34 (17.1%)4 80 (40.2%)2.4 10 (10.6%)4 46 (48.9%)3.4 24 (13.5%)4 60 (33.7%) 0 (0%) 3 (33.3%) 57 (11.7%) 187 (38.4%) 70 (33.9%) 123 (59.7%)# Hemoptysis 3 (1.5%) 4 (2.0%) 0 (0%) 0 (0%) 11 (6.2%) 39 (21.9%)3.4 0 (0%) 0 (0%) 14 (2.9%) 28 (5.3%) 25 (12.1%) 50 (24.2%) Hoarseness 0 (0%) 8 (4.0%)4 0 (0%) 1 (1.1%) 0 (0%) 8 (4.5%)4 0 (0%) 0 (0%) 0 (0%) 11 (2.3%) 0 (0%) 2 (0.9%) Swelling of the legs/feet 30 (15.1%) 62 (31.2%) 15 (15.9%) 32 (34.0%) 22 (12.4%) 71 (39.9%)4 1 (11.1%) 2 (22.2%) 60 (12.3%) 182 (37.4%)# 46 (22.3%) 146 (68.4%)#
vs. baseline; 1:
; 2:
; 3:
; 4:
vs. PoPH
.